BioCrossroads Welcomes Vince Wong as President and CEO

2024-01-31T09:05:19-05:00January 31, 2024|

In a pivotal moment for Indiana’s life sciences sector, Vince will play a crucial role in championing the newly released life sciences industry strategy. INDIANAPOLIS — Following a thorough national search, BioCrossroads, a catalyst for Indiana's life sciences sector, today announced the appointment of Vince Wong as its new president and CEO. An esteemed leader with a rich background in healthcare and life sciences, Vince takes the helm at BioCrossroads ready to harness his vast expertise to elevate the organization’s impact on Indiana’s life sciences ecosystem. Vince’s extensive experience at both multinational and venture backed start-up life science companies, coupled with deep-rooted insights into the life sciences sector, both locally and nationally, position him as a visionary leader who will help drive the recently released life sciences strategy for Indiana. Read the report: TEConomy Partners: A Strategic Roadmap for Advancing [...]

Igniting an Industry: A Strategic Vision for Indiana’s Future as a Global Leader in Life Sciences

2024-01-09T00:42:32-05:00January 8, 2024|

Collaborative efforts in four key areas will establish Indiana as the leading state for advancing innovations into products that improve health and well-being INDIANAPOLIS – Marking a significant milestone since Indiana’s designation as a federal Tech Hub in October 2023, BioCrossroads today unveils a groundbreaking strategic framework poised to catapult Indiana to the forefront of the global life sciences sector. This comprehensive industry strategy, crafted in collaboration with TEConomy Partners, is set to transform Indiana’s life sciences landscape, focusing on four pivotal areas: Fostering research and development and innovation Enhancing the state’s life sciences manufacturing ecosystem Boosting Indiana’s life sciences talent and workforce Supporting connections and outreach across the sector This strategy is set to transform Indiana’s life sciences sector through the development of strategic manufacturing hubs and targeted investments that enhance the state's domestic manufacturing capabilities. These efforts are [...]

IU School of Medicine’s Bruce Lamb named BioCrossroads’ 2023 Watanabe Life Sciences Champion

2023-11-09T16:51:59-05:00November 9, 2023|

Researcher has contributed on a global scale to efforts to overcome Alzheimer’s disease INDIANAPOLIS — The BioCrossroads Board of Directors today named Bruce T. Lamb, PhD, as the recipient of the 2023 August M. Watanabe Life Sciences Champion of the Year Award. Lamb is the executive director of the Stark Neurosciences Research Institute at Indiana University School of Medicine and co-director of the Neurosciences Institute, a partnership between Indiana University Health and IU School of Medicine. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Lamb at today’s Indiana Life Sciences Summit in recognition of his globally significant research into the causes of and potential treatments for Alzheimer’s disease as well as his many years of advocacy to increase research funding and raise awareness for challenges the disease brings to families and caregivers. “As [...]

BioCrossroads Book of Data and Organizations goes digital to serve as Indiana’s wiki for health data assets

2023-05-09T16:06:42-04:00May 9, 2023|

INDIANAPOLIS (May 9, 2023) – BioCrossroads today released the seventh edition of its Book of Data and Organizations and announced that the resource used to foster collaboration and networking among Indiana’s growing network of healthcare and life sciences companies, organizations and professionals, will now be available only in digital form on the organizations’ website under the Resources/Network tab. “This resource has quintupled in size since we first created it in 2020 and is used to help health data professionals and others become more aware of the data, talent, and technology resources available, and build solutions where there are gaps,” said Darshan Shah, senior vice president and chief data officer for BioCrossroads. “Now, as a wiki, it will be an even better resource to help drive collaboration across the sector.” Indiana’s life sciences sector contributed $77 billion to the state’s economic [...]

BioCrossroads adds new members to Board of Directors 

2023-04-30T14:29:50-04:00April 27, 2023|

INDIANAPOLIS (April 27, 2023) – BioCrossroads, Indiana’s initiative to grow the state’s life sciences sector, today announced seven new members to its board of directors. Central Indiana Corporate Partnership (CICP) President Latoya Botteron Purdue University Indianapolis Launch Leader Daniel J. Hasler Central Indiana Corporate Partnership CEO Melina Kennedy Langham Logistics Inc. Founder, Owner and President Cathy Langham University of Notre Dame Professor and Dean of the College of Science Santiago Schnell Indiana University Provost and Executive Vice President Rahul Shrivastav LabCorp Drug Development Senior Vice President – Head of Enterprise Client Solution and Business Strategy Stacey Yount  “We are delighted to welcome these leaders and innovators to our board and look forward to benefiting from their vast experience, skills and intellect,” said Dan Peterson, board chair for BioCrossroads. “Indiana’s life sciences sector has experienced tremendous growth over the past 20 [...]

BioCrossroads releases 2022 Indiana Life Sciences Capital Report showing $6.8B in capital investment in the life sciences sector  

2023-04-17T08:34:34-04:00April 17, 2023|

INDIANAPOLIS (April 17, 2023) — BioCrossroads today released its annual analysis of capital invested to grow and support Indiana life sciences companies in 2022. “We are pleased to report that Indiana experienced capital investment of more than $6.8 billion in 2022 that will directly result in the creation of 3,000 new life sciences sector jobs in the state,” said Jane Dunigan-Smith, BioCrossroads’ senior vice president, chief strategy officer and managing director of Seed Funds. “This includes more than $600 million in venture capital to support innovation and start-ups along with $2.8 billion in other capital investments for establishing, expanding or upgrading Indiana life sciences facilities.” Indiana’s life sciences sector contributed $77 billion to the state’s economy last year. Total market cap value grew by 20 percent over 2021, from $455.7 billion to $548.7 billion, driven largely by Eli Lilly and [...]

IBJ: Life Sciences Industry Booster BioCrossroads Girds for New Challenges

2023-03-31T09:19:03-04:00March 27, 2023|

A recent Indianapolis Business Journal (IBJ) article takes a look back at 20 years of success for BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP). In two decades, BioCrossroads has assisted more than 500 startup companies, raised more than $600 million of market capital and helped attract thousands of jobs. In 2022, data shows that Indiana leads the United States in pharmaceutical sales and is one of three top states for exports of all life sciences products - pharmaceuticals, medical devices, and agbiosciences, while providing an $80 billion economic impact. In 2023, BioCrossroads announced that President and CEO Patty Martin would step down to pursue other ventures. “I think it’s just a logical time right now to take a couple of months and really take a good hard, informed look at where we are overall,” said [...]

BioCrossroads names new members to leadership team

2023-03-21T15:25:53-04:00March 21, 2023|

INDIANAPOLIS (March 21, 2023) — BioCrossroads announced today that Jane Dunigan-Smith and Mike Bolinder have joined the organization’s leadership team. Dunigan-Smith, senior vice president, chief strategy officer and managing director of Seed Funds, comes to BioCrossroads after 19 years with Eli Lilly and Company where she spent a significant portion of her career in commercialization, corporate strategy and operations. She also has a strong background in accounting and finance, having spent the early part of her career as a Certified Public Accountant, and serves on the boards of Diagnotes, Inc. and Allinaire Therapeutics. “Jane’s multi-faceted experience positions her to manage the Seed Funds and lead our strategy at a time when Indiana’s life sciences sector is expanding and innovating in multiple areas,” said Patty Martin, president and CEO, BioCrossroads. “One example is our work to establish Indiana as a global [...]

Go to Top